Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
NVIDIA
NVDA
|
$1B |
| 2 |
Netflix
NFLX
|
$721M |
| 3 |
Apple
AAPL
|
$468M |
| 4 |
UnitedHealth
UNH
|
$422M |
| 5 |
GE Vernova
GEV
|
$376M |
Top Sells
| 1 |
Broadcom
AVGO
|
$673M |
| 2 |
Robinhood
HOOD
|
$481M |
| 3 |
Meta Platforms (Facebook)
META
|
$433M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$402M |
| 5 |
Palantir
PLTR
|
$380M |
Sector Composition
| 1 | Technology | 19.67% |
| 2 | Healthcare | 15.34% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Financials | 11.51% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Broadwind
BWEN
$47.2M
| $118K | ﹤0.01% |
65,400
+4,200
| +7% | +$7.6K |
|
3277
Sono-Tek
SOTK
$61.7M
| $116K | ﹤0.01% |
31,000
-1,200
| -4% | -$4.5K |
|
3278
Cambium Networks
CMBM
$18.4M
| $116K | ﹤0.01% |
286,427
-165,056
| -37% | -$66.8K |
|
3279
Loop Industries
LOOP
$88.8M
| $116K | ﹤0.01% |
+81,428
| New | +$116K |
|
3280
Q32 Bio
QTTB
$20.4M
| $115K | ﹤0.01% |
+77,000
| New | +$115K |
|
3281
DURECT Corp
DRRX
$59.3M
| $113K | ﹤0.01% |
177,766
+5,300
| +3% | +$3.37K |
|
3282
Wheels Up
UP
$1.4B
| $112K | ﹤0.01% |
+104,500
| New | +$112K |
|
3283
Xilio Therapeutics
XLO
$36.3M
| $112K | ﹤0.01% |
164,200
-13,500
| -8% | -$9.18K |
|
3284
Freightos
CRGO
$158M
| $112K | ﹤0.01% |
45,900
+17,400
| +61% | +$42.3K |
|
3285
Ribbon Communications
RBBN
$707M
| $110K | ﹤0.01% |
27,500
-117,312
| -81% | -$470K |
|
3286
Lipocine
LPCN
$15.7M
| $110K | ﹤0.01% |
34,797
-2,713
| -7% | -$8.57K |
|
3287
SCYNEXIS
SCYX
$37.3M
| $108K | ﹤0.01% |
159,800
+2,200
| +1% | +$1.49K |
|
3288
HilleVax
HLVX
$105M
| $108K | ﹤0.01% |
54,100
+26,500
| +96% | +$52.7K |
|
3289
Vertical Aerospace
EVTL
$454M
| $107K | ﹤0.01% |
15,800
-6,909
| -30% | -$46.8K |
|
3290
Marker Therapeutics
MRKR
$11.6M
| $106K | ﹤0.01% |
69,442
-14,073
| -17% | -$21.5K |
|
3291
Forafric Global
AFRI
$221M
| $106K | ﹤0.01% |
13,600
+1,000
| +8% | +$7.8K |
|
3292
Bolt Biotherapeutics
BOLT
$9.96M
| $106K | ﹤0.01% |
18,325
+2,618
| +17% | +$15.1K |
|
3293
BTCS Inc
BTCS
$202M
| $105K | ﹤0.01% |
+47,900
| New | +$105K |
|
3294
Oric Pharmaceuticals
ORIC
$1.06B
| $104K | ﹤0.01% |
+10,200
| New | +$104K |
|
3295
Arena Group
AREN
$300M
| $103K | ﹤0.01% |
16,600
-21,200
| -56% | -$131K |
|
3296
Codere Online
CDRO
$376M
| $101K | ﹤0.01% |
+11,900
| New | +$101K |
|
3297
Southland Holdings
SLND
$227M
| $100K | ﹤0.01% |
+24,000
| New | +$100K |
|
|
BNR
3298
Burning Rock Biotech
BNR
$89.4M
| $100K | ﹤0.01% |
31,717
| – | – |
|
3299
Dominari Holdings
DOMH
$90.9M
| $97.5K | ﹤0.01% |
17,926
-30,200
| -63% | -$164K |
|
3300
Siebert Financial
SIEB
$101M
| $97.2K | ﹤0.01% |
22,000
-16,800
| -43% | -$74.3K |
|